Effect of HT042, herbal formula, on longitudinal bone growth in spontaneous dwarf rats

12Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

HT042 is a new herbal prescription consisting of Astragalus membranaceus, Phlomis umbrosa and Eleutherococcus senticosus, which are used in Korean medicine to stimulate growth in children. We investigated the effects of HT042 on the body weight, longitudinal bone growth, and bone length in spontaneous dwarf rats (SDR). Male and female SDRs were divided into three groups: the control group (DW, 10 mL/kg/day), the recombinant human GH group (rhGH; 500 μg/kg/day), and the HT042 (100 mg/kg/day) group. Each group received the respective treatments for 10 days. Body weight was measured on day 10 of treatment. On day 8, tetracycline (20 mg/kg) was injected intraperitoneally into all individuals to form a fluorescent band on the newly synthesized bone. On day 10, femur and tibia lengths were measured using PIXImus. Body weight, longitudinal bone growth, and bone length were not affected in the HT042 group. In contrast, the rhGH group showed significantly increased body weight, longitudinal bone growth, and bone length. In conclusion, HT042 does not act through a GH-like effect to promote longitudinal bone growth. © 2013 by the authors.

Cite

CITATION STYLE

APA

Kim, J. Y., Song, M., Lee, D., Song, J., Park, S. W., Park, J., … Kim, H. (2013). Effect of HT042, herbal formula, on longitudinal bone growth in spontaneous dwarf rats. Molecules, 18(11), 13271–13282. https://doi.org/10.3390/molecules181113271

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free